Metformin suppresses high glucose-induced poly(adenosine diphosphate-ribose) polymerase overactivation in aortic endothelial cells

Metabolism: Clinical and Experimental

Volumn 58, Issue 4, 2009, Pages 525-533

  Mahrouf Yorgov, Meriem ^a   Marie, Nicolas ^b   Borderie, Didier ^a   Djelidi, Raja ^a   Bonnefont Rousselot, Dominique ^a   Legrand, Alain ^a   Beaudeux, Jean Louis ^a,c   Peynet, Jacqueline ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CNRS   (France)

^c HÔPITAL CHARLES FOIX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALPHOSTIN; DIHYDRORHODAMINE 123; DIPHENYLIODONIUM SALT; GLUCOSE; METFORMIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXYNITRITE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE P47PHOX; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COW; ENDOTHELIUM CELL; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, WESTERN; CATTLE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; HYPOGLYCEMIC AGENTS; METFORMIN; POLY(ADP-RIBOSE) POLYMERASES;

EID: 62649094919     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.11.012     Document Type: Article

References (61)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
2. Pacher P., Obrosova I.G., Mabley J.G., and Szabo C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 12 (2005) 267-275
3. Mabley J.G., and Soriano F.G. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic vascular dysfunction. Curr Vasc Pharmacol 3 (2005) 247-252
4. Nishikawa T., and Araki E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 9 (2007) 343-353
5. Shah S., Iqbal M., Karam J., Salifu M., and McFarlane S.I. Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: pathophysiological insights. Antioxid Redox Signal 9 (2007) 911-929
6. Inoguchi T., Li P., Umeda F., Yu H.Y., Kakimoto M., Imamura M., et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49 (2000) 1939-1945
7. Inoguchi T., Sonta T., Tsubouchi H., Etoh T., Kakimoto M., Sonoda N., et al. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol 14 (2003) 227-232
8. Kiss L., and Szabo C. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity. Mem Inst Oswaldo Cruz 1 (2005) 29-37
9. Pacher P., and Szabo C. Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme. Antioxid Redox Signal 7 (2005) 1568-1580
10. Szabo C., Biser A., Benko R., Bottinger E., and Susztak K. Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice. Diabetes 55 (2006) 3004-3012
11. Ha H.C., Hester L.D., and Snyder S.H. Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci U S A 99 (2002) 3270-3275
12. Reusch J.E.B. Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose?. J Clin Invest 112 (2003) 986-988
13. Du X., Matsumura T., Edelstein D., Rossetti L., Zsengellér Z., Szabó C., et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112 (2003) 1049-1057
14. Horvath E.M., and Szabo C. Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update. Drug News Perspect 20 (2007) 171-181
15. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352 (1998) 854-865
16. Wiernsperger N.F. Metformin: intrinsic vasculoprotective properties. Diabetes Technol Ther 2 (2000) 259-272
17. Sartoretto J.L., Melo G.A., Carvalho M.H., Nigro D., Passaglia R.T., Scavone C., et al. Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression. Life Sci 77 (2005) 2676-2689
18. Majithiya J.B., and Balaraman R. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats. Life Sci 78 (2006) 2615-2624
19. Pavlović D., Kocić R., Kocić G., Jevtović T., Radenković S., Mikić D., et al. Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes. Diabetes Obes Metab 2 (2000) 251-256
20. Isoda K., Young J.L., Zirlik A., MacFarlane L.A., Tsuboi N., Gerdes N., et al. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arterioscler Thromb Vasc Biol 26 (2006) 611-617
21. Ouslimani N., Peynet J., Bonnefont-Rousselot D., Therond P., Legrand A., and Beaudeux J.L. Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells. Metabolism 54 (2005) 829-834
22. Bellin C., de Wiza D.H., Wiernsperger N.F., and Rosen P. Generation of reactive oxygen species by endothelial and smooth muscle cells: influence of hyperglycemia and metformin. Horm Metab Res 38 (2006) 732-739
23. Ouslimani N., Mahrouf M., Peynet J., Bonnefont-Rousselot D., Cosson C., Legrand A., et al. Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1. Metabolism 56 (2007) 308-313
24. Owen M.R., Doran E., and Halestrap A.P. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348 (2000) 607-614
25. Detaille D., Guigas B., Leverve X., Wiernsperger N., and Devos P. Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function. Biochem Pharmacol 63 (2002) 1259-1272
26. Gallo A., Ceolotto G., and Pinton P. Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism. Diabetes 54 (2005) 1123-1131
27. Mahrouf M., Ouslimani N., Peynet J., Djelidi R., Couturier M., Therond P., et al. Metformin reduces angiotensin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase C. Biochem Pharmacol 72 (2006) 176-183
28. Rajesh M., Mukhopadhyay P., Bátkai S., Haskó G., Liaudet L., Drel V.R., et al. Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am J Physiol Heart Circ Physiol. 293 (2007) H610-H619
29. Hancock J.T., and Jones Owen T.G. The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. Biochem J 242 (1987) 103-107
30. Bakondi E., Bai P., Szabó É., Hunyadi J., Gergely P., Szabó C., et al. Detection of poly(ADP-ribose) polymerase activation in oxidatively stressed cells and tissues using biotinylated NAD substrate. J Histochem Cytochem 50 (2002) 91-98
31. Allen D.A., Harwood S.M., Varagunam M., Raftery M.J., and Yaqoob M.M. High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J 17 (2003) 908-910
32. Gomes A., Fernandes E., and Lima J.L. Use of fluorescence probes for detection of reactive nitrogen species: a review. J Fluoresc 16 (2006) 119-139
33. Pacher P., Liaudet L., Soriano F.G., Mabley J.G., Szabo E., and Szabo C. The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51 (2002) 514-521
34. Szabo C. PARP as a drug target for the therapy of diabetic cardiovascular dysfunction. Drug News Perspect 15 (2002) 197-205
35. Oumouna-Benachour K., Hans C.P., and Suzuki Y. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Circulation 115 (2007) 2442-2450
36. Li F., Szabo C., Pacher P., Southan G.J., Abatan O.I., Charniauskaya T., et al. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy. Diabetologia 47 (2004) 710-717
37. Li F., Drel V.R., Szabo C., Stevens M.J., and Obrosova I.G. Low-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy. Diabetes 54 (2005) 1514-1522
38. Obrosova I.G., Li F., Abatan O.I., Forsell M.A., Komjati K., Pacher P Szabo C., et al. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 53 (2004) 711-720
39. Ilnytska O., Lyzogubov V.V., and Stevens M.J. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes 55 (2006) 1686-1694
40. Zheng L., Szabó C., and Kern T.S. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-κB. Diabetes 53 (2004) 2960-2967
41. Szabo' C., Zanchi A., Komjati K., Pacher P., Krolewski A.S., et al. Poly(ADP-ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 106 (2002) 2680-2686
42. Adaikalakoteswari A., Rema M., Mohan V., and Balasubramanyam M. Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy. Int J Biochem Cell Biol 39 (2007) 1673-1684
43. Pacher P., and Szabó C. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr Opin Pharmacol 6 (2006) 136-141
44. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87 (2007) 315-424
45. Pacher P., and Szabo C. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol 173 (2008) 2-13
46. Zou M.H., Shi C., and Cohen R.A. High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51 (2002) 198-203
47. Ceriello A., Mercuri F., Quagliaro L., Assaloni R., Motz E., Tonutti L., et al. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 44 (2001) 834-838
48. Ceriello A., Quagliaro L., Catone B., Pascon R., Piazzola M., Bais B., et al. Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 25 (2002) 1439-1443
49. Obrosova I.G., Drel V.R., Pacher P., Ilnytska O., Wang Z.Q., Stevens M.J., et al. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 54 (2005) 3435-3441
50. Pieper A.A., Brat D.J., Krug D.K., Watkins C.C., Gupta A., Blackshaw S., et al. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96 (1999) 3059-3064
51. Soriano F.G., Pacher P., Mabley J., Liaudet L., and Szabo C. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ Res 89 (2001) 684-691
52. Pricci F., Leto G., Amadio L., Iacobini C., Cordone S., Catalano S., et al. Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C. Free Radic Biol Med 35 (2003) 683-694
53. Onozato M.L., Tojo A., Goto A., Fujita T., and Wilcox C.S. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int 61 (2002) 186-194
54. Kitada M., Koya D., Sugimoto T., Isono M., Araki S., Kashiwagi A., et al. Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes 52 (2003) 2603-2614
55. Li Y., and Trush M.A. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Commun 253 (1998) 295-299
56. Liu S., Ma X., Gong M., Shi L., Lincoln T., and Wang S. Glucose down-regulation of cGMP-dependent protein kinase I expression in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species. Free Radic Biol Med 42 (2007) 852-863
57. Fontayne A., Dang P.M., Gougerot-Pocidalo M.A., and El-Benna J. Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 41 (2002) 7743-7750
58. Ungvari Z., Csiszar A., Huang A., Kaminski P.M., Wolin M.S., and Koller A. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation 108 (2003) 1253-1258
59. Sartoretto J.L., Melo G.A., Carvalho M.H., Nigro D., Passaglia R.T., Scavone C., et al. Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity but not NOS expression. Life Sci 77 (2005) 2676-2689
60. Kumar V.B., Bernardo A.E., Vyas K., Franko M., Farr S., Lakshmanan L., et al. Effect of metformin on nitric oxide synthase in genetically obese (ob/ob) mice. Life Sci 69 (2001) 2789-2799
61. El-Mir M.Y., Nogueira V., Fontaine E., Averet N., Rigoulet M., and Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 275 (2000) 223-228